To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)

NCT06264310 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Worsening Heart Failure (WHF)

Interventions

DRUG: Placebo
DRUG: R2R01

Sponsor

River 2 Renal Corp.

Collaborators

[object Object]